F.D.A. Approves Pfizer’s R.S.V. Vaccine for Older Adults

Health
By BY CHRISTINA JEWETT from NYT Health https://ift.tt/6g1jNU4
via IFTTT Drugs (Pharmaceuticals), Vaccination and Immunization, Elderly, Respiratory Syncytial Virus (RSV), Guillain-Barre Syndrome, Winter (Season), Viruses Though agency advisers had some safety concerns, the Pfizer shot is expected to be available before the winter R.S.V. season.

Comments

Popular posts from this blog

Should the Autism Spectrum Be Split Apart?

The Jarring Contradiction at the Heart of Kennedy’s Agenda